# K2bio

> K2bio is a Houston-based preclinical contract research organization (CRO) built on assets acquired from Bellicum Pharmaceuticals, including a certified mouse vivarium. It pairs full-service GLP and non-GLP in vivo and in vitro research with flexible private and shared lab space near the Texas Medical Center, giving early-stage biotech and pharma teams big-company infrastructure on small-company budgets.

- **Founded:** 2021
- **Headquarters:** Houston, Texas, United States
- **Founders:** Andrew Strong (Co-Founder & Board Chair), Kevin Slawin (Founding Board Member & Investor)
- **Team size:** ~16 employees
- **Products:** Vivarium & Animal Studies, In Vivo Pharmacology, In Vitro & Lab Services, Lab Space & Scientific Infrastructure, R&D & Scale-Up Support
- **Notable:** AAALAC-accredited vivarium, OLAW-certified animal research program, Registered Scientist.com supplier

## Products & services

- **Vivarium & Animal Studies** — AAALAC-accredited, OLAW-certified vivarium offering in vivo study design and execution, IACUC protocols, surgical procedures, efficacy models, PK/PD studies, and necropsy.
- **In Vivo Pharmacology** — Efficacy and pharmacology studies including tumor and immuno-oncology models, tissue volume measurements, and bioluminescence/fluorescence imaging.
- **In Vitro & Lab Services** — Cell-based and analytical work supporting assay development, biomarker discovery/validation, and analytical method development.
- **Lab Space & Scientific Infrastructure** — Private labs, shared bench areas, instrumentation, controlled utilities, offices, and conference rooms near the Texas Medical Center - available on flexible terms.
- **R&D & Scale-Up Support** — GLP and non-GLP support, tech transfer, process development, and scale-up toward product commercialization, tailored to a client's phase and goals.

## Achievements

- AAALAC-accredited vivarium
- OLAW-certified animal research program
- Registered Scientist.com supplier
- Built a functioning CRO from assets acquired out of Bellicum Pharmaceuticals
- Raised a seed round led by Rapha Capital Management

## Latest updates

- **2023-08** — Closed a seed funding round (~$616K) with Rapha Capital Management.
- **2021-06** — Launched in Houston as a biotechnology research accelerator, with Ponce Therapeutics as first tenant and investor.

## Links

- Website: https://www.k2-biolabs.com
- LinkedIn: http://www.linkedin.com/company/k2-biolabs

---

Profile page: https://yespress.io/k2bio
Published by YesPress — https://yespress.io
Last updated: 2026-08-04